Revera | Jotup

Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Regulatory and Corporate Update

Retrieved on:

Thursday, March 21, 2024

MONTREAL and CHARLOTTE, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the fourth quarter and year ended December 31, 2023 and provided a regulatory and corporate update.

Key Points:

- FDA reiterated prior guidance on regulatory pathway for AFib-RVR, End of Phase 2 Meeting expected mid-2024
MONTREAL and CHARLOTTE, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the fourth quarter and year ended December 31, 2023 and provided a regulatory and corporate update.
There was no revenue recorded for the fourth quarter of 2023, compared with $3.5 million the fourth quarter of 2022.
Commercial expense for the fourth quarter of 2023 was $5.0 million, compared with $2.6 million for the prior year period.
For the fourth quarter of 2023, net loss was $13.6 million, compared to $13.2 million for the prior year period.

Extendicare Announces 2023 Third Quarter Results

Retrieved on:

Thursday, November 9, 2023

MARKHAM, Ontario, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and nine months ended September 30, 2023.

Key Points:

MARKHAM, Ontario, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and nine months ended September 30, 2023.
Subsequent to the end of the quarter and under the enhanced capital funding subsidy that was in place until August 31, 2023, Extendicare commenced construction on a new 256-bed LTC home in Ottawa.
ADV in the third quarter was 27,378, a 1% increase from Q2 2023 and up 9.3% from Q3 2022.
Overall occupancy in the third quarter was up 60 bps to 97.8% from Q2 2023, with improvements in preferred occupancy reflecting strong demand.

Milestone Pharmaceuticals to Host Investor and Analyst Webcast to Review Data from ReVeRA Phase 2 Study of Etripamil in AFib-RVR

Retrieved on:

Tuesday, November 7, 2023

Cardiac Electrophysiology Key Opinion Leaders joining the webcast include A. John Camm, MD, and Sean Pokorney, MD

Key Points:

Cardiac Electrophysiology Key Opinion Leaders joining the webcast include A. John Camm, MD, and Sean Pokorney, MD
Conference call and webcast on Monday, November 13, 2023 at 8:00 a.m.
ET
MONTREAL and CHARLOTTE, N.C., Nov. 7, 2023 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that the Company will host a virtual investor and analyst webcast on Monday, November 13, 2023 at 8:00 a.m.
The webcast will focus on results from the ReVeRA Phase 2 study of investigational new drug etripamil in patients with atrial fibrillation with rapid ventricular rate (AFib-RVR), which is being presented as a Featured Science presentation at the American Heart Association (AHA) Scientific Sessions 2023.
To access a live or recorded webcast of the event and accompanying slides, please visit the News & Events section of Milestone's investor relations website at investors.milestonepharma.com .

Extendicare Announces Closing of Transaction with Axium

Retrieved on:

Wednesday, September 13, 2023

International joint venture, Partnership, Bed, LTC, Long-term care, Tax, Joint venture, Sale, JV, Extendicare, TSX, Growth, Life insurance, Revera

MARKHAM, Ontario, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that, effective September 13, 2023, it has completed the previously announced transaction with a fund managed by Axium Infrastructure Inc. and its affiliates (“Axium”) to form a limited partnership joint venture, Axium Extendicare LTC LP (the “Joint Venture”), to redevelop certain of Extendicare’s Class C long-term care (“LTC”) homes, in which Extendicare will retain a 15% managed interest.

Key Points:

MARKHAM, Ontario, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that, effective September 13, 2023, it has completed the previously announced transaction with a fund managed by Axium Infrastructure Inc. and its affiliates (“Axium”) to form a limited partnership joint venture, Axium Extendicare LTC LP (the “Joint Venture”), to redevelop certain of Extendicare’s Class C long-term care (“LTC”) homes, in which Extendicare will retain a 15% managed interest.
“The closing of the Axium transaction, coupled with the recent closing of the Revera transaction, marks a significant milestone in Extendicare’s strategic repositioning to a less capital-intensive, higher margin business model to drive growth in our long-term care and home health care segments,” said President and CEO, Dr. Michael Guerriere.
“The need to replace aging long-term care infrastructure is a serious issue for the health sector.
Our partnership with Axium positions us to build more homes faster, while continuing to advance our mission to provide high-quality care for seniors across Canada,” added Dr. Guerriere.

Extendicare Announces 2023 Second Quarter Results

Retrieved on:

Thursday, August 10, 2023

MARKHAM, Ontario, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2023.

Key Points:

MARKHAM, Ontario, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2023.
Revera transactions closed on August 1, 2023, adding 56 LTC homes and approximately 7,000 beds to our Extendicare Assist and SGP managed services portfolio.
We are targeting to start an additional project in 2023 under the enhanced capital funding subsidy that is in place until August 31, 2023.
ADV in the second quarter was 27,102, marking a 4.1% increase relative to Q1 2023 and up 7.7% from Q2 2022.

Extendicare Announces Closing of Transactions with Revera

Retrieved on:

Tuesday, August 1, 2023

MARKHAM, Ontario, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare”) (TSX: EXE.TO) announced today that it has completed the previously announced transactions with Revera Inc. and its affiliates (“Revera”) in respect of the ownership, operation and redevelopment of long-term care homes in Ontario and Manitoba.

Key Points:

MARKHAM, Ontario, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare”) (TSX: EXE.TO) announced today that it has completed the previously announced transactions with Revera Inc. and its affiliates (“Revera”) in respect of the ownership, operation and redevelopment of long-term care homes in Ontario and Manitoba.
For further information on the transactions with Revera and Axium, please refer to the discussion in Extendicare’s 2022 Annual Information Form under the section “General Development of the Business – Acquisitions and Dispositions – Revera and Axium Transactions” which is available on Sedar at www.sedar.com.
BMO Capital Markets acted as financial advisor to Extendicare and Torys LLP acted as legal advisor to Extendicare in connection with these transactions.
Stormont Partners Advisory acted as financial advisor to Revera and Goodmans LLP acted as legal advisor to Revera in connection with the Revera transactions.

GLENORA PARK RETIREMENT RESIDENCE UNVEILS CLIFTON PARK IN EDMONTON

Retrieved on:

Wednesday, June 21, 2023

Park, Partnership, Skytop Lounge, AB, Edmonton, Quality of life, Recreation, Retirement, Glenora, Museum, Humanity, Environment, Mixed-use development, Tourism, Hotel, Revera, Takanini

After a ceremonial ribbon-cutting, members of the media and the local community were invited to tour the 290-suite residence and attend a culinary experience called “Taste of Glenora Park”.

Key Points:

After a ceremonial ribbon-cutting, members of the media and the local community were invited to tour the 290-suite residence and attend a culinary experience called “Taste of Glenora Park”.
“At Glenora Park, we tailor a unique senior living experience for each of our residents, and we are excited to incorporate Clifton Park into that specialized offering,” said JP Cadeau, President of Revera Canada.
Through our partnership with ONE Properties, this residence will make Edmonton an even more popular retirement living destination for Canadians.”
Glenora Park, which welcomed its first residents in October, is a joint venture between ONE Properties and Revera whose residents will make regular use of Clifton Park.
“The addition of a newly unveiled Clifton Park will only enhance the quality of life for Glenora Park residents and create a meeting place with the broader local community.

Extendicare Announces 2023 First Quarter Results

Retrieved on:

Thursday, May 4, 2023

MARKHAM, Ontario, May 04, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2023.

Key Points:

MARKHAM, Ontario, May 04, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2023.
We are advancing our comprehensive integration plan with the expectation that the transaction will close by the end of the third quarter of 2023.
The timing mismatch between the incurrence of COVID-19 costs and their reimbursement continued to drive volatility in our financial results this quarter.
With pandemic impacts waning, we expect the significant volatility we have seen in our financial results to subside as we enter Q2 2023.

Extendicare Announces 2022 Fourth Quarter and Year End Results

Retrieved on:

Thursday, March 2, 2023

MARKHAM, Ontario, March 02, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2022.

Key Points:

MARKHAM, Ontario, March 02, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2022.
Average long-term care (“LTC”) occupancy improved by 100 bps to 94.5%(1) from Q3 2022 despite persistent COVID-19 outbreaks, which drove elevated costs.
Home health care average daily volumes (“ADV”) up 2.0% from Q3 2022; 90 bps improvement in NOI margins from Q3 2022 excluding net COVID costs.
Governments continue to provide support for elevated pandemic costs, although the extent and timing of funding lagged, putting pressure on our financial results in the quarter.

Nova Announces Leadership Changes

Retrieved on:

Tuesday, February 21, 2023

Trust, Waisman, Revera, Growth, CBO, President's Management Advisory Board, Environment, Management

REHOVOT, Israel, Feb. 21, 2023 /PRNewswire/ -- Nova (Nasdaq: NVMI) today announced changes in senior leadership positions. Gaby Waisman, who has served as the Company's Chief Business Officer since 2016, has been appointed as CEO and President. Eitan Oppenhaim, who has served as Nova's CEO and President since 2013, has been appointed as Executive Chairman of the Board, succeeding Micha Brunstein. The changes will be effective March 31, 2023.

Key Points:

Gaby Waisman to succeed Eitan Oppenhaim as President & CEO;
REHOVOT, Israel, Feb. 21, 2023 /PRNewswire/ -- Nova (Nasdaq: NVMI) today announced changes in senior leadership positions.
During his tenure as CEO, Nova accelerated its growth while strengthening the company's position across industry segments, territories, and customers.
"I am pleased to announce Gaby's appointment as Nova's CEO and President," said Avi Cohen, Nova Interim Chairman of the Board.
"All of us on the Board of Directors wholeheartedly entrust Gaby with the leadership of this great Company and are confident Nova is positioned for further success in the years to come.